Contact

Integrated drug
discovery expertise

Full-spectrum drug discovery capabilities - without the overhead of a large CRO

logo-ISO9001-2

Talk to our team

Explore our services

The problem > the solution

You discovered it.
We’ll help you develop it.

The Challenge

  • You have a hit but no chemistry team to advance it.
  • Coordinating multiple CROs is slow and expensive.
  • Big CROs treat you like a ticket number.

How Oxeltis solves it

  • You have a hit but no chemistry team to advance it.
  • Coordinating multiple CROs is slow and expensive.
  • Big CROs treat you like a ticket number.

Our model - THE CONSORTIUM

Three specialists. One team. Zero overhead.

Computational chemistry, SBDD, virtual screening

Medicinal chemistry, custom synthesis, 16+ years

Biological screening, ADME, in vitro assays

Learn more about our model
oxeltis

1 single point
of contact

oxeltis

Specialist
depth

Optimized
costs

oxeltis

Transparent
collaboration

SERVICES OVERVIEW

End-to-end drug discovery
expertise

Hit Discovery
Hit-To-Lead
Lead Optimization
PROTAC Services
Assay development and Biological Screening
Custom Synthesis and Route Scouting
Computer Assisted Drug Design

WHO WE SERVE

Built for teams who need
deep expertise and agile
delivery

Technology Transfer

You have an academic hit that needs industry-ready maturation

Hit Discovery

Startups & Biotechs

You have the science but not the chemistry team

See how we help

Pharma & Mid-Size

You need niche expertise your internal team doesn’t cover

See how we help
fff (2)
fff (2)
fff (2)
fff (2)
fff (2)
fff (2)
fff (2)
fff (2)

Case studies

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi aliquam dignissim porta. Vivamus tempor pellentesque nisl id pretium. Nullam vitae vehicula velit, vel fermentum justo. Pellentesque dictum vel nisi eget commodo. Sed volutpat dignissim gravida.

Michel Bellemare
Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi aliquam dignissim porta. Vivamus tempor pellentesque nisl id pretium. Nullam vitae vehicula velit, vel fermentum justo. Pellentesque dictum vel nisi eget commodo. Sed volutpat dignissim gravida.

Michel Bellemare
Lorem ipsum dolor sit amet

All case studies
PhDs on the team
35 %
PLorem ipsum
35 +
MS on the team
35 %
Years of expertise
0 +
Nucleoside compounds

Ready to advance your drug discovery program?

Schedule a call with our team or request a quote

News & Event

All the latest news & events from the Oxeltis group

Oxeltis at the gordon conference 2025

Read

1ˢᵗ French Day of Therapeutic Oligonucleotides – A Great Collective Success!

Read
All the news & Events